(Q79495894)

English

Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis

scientific article published on 04 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Nakase K

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kita K

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Miwa H

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Nishii K

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Shikami M

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Tanaka I

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Tsutani H

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ueda T

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Nasu K

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Kyo T

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Dohy H

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Shiku H

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Katayama N

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

4 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

326-332

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17205058%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404497

0 references

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine control of developmental programs in normal hematopoiesis and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence of cytokine receptors on different lymphoid leukaemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor alpha chain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperati

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404497

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79495894&oldid=1949296484"